Literature DB >> 8921477

Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea.

H R Shin1, C U Lee, H J Park, S Y Seol, J M Chung, H C Choi, Y O Ahn, T Shigemastu.   

Abstract

BACKGROUND: Liver cancer mortality in Korea is the highest in the world. Hepatitis B and C viruses (HBV, HCV) are known to be the major risk factors of hepatocellular carcinoma (HCC). Cholangiocarcinoma (CLG) accounts for more than 20% of liver cancer in the Pusan area. In Korea, the different roles of known risk factors in the development of HCC or CLG have not been adequately evaluated.
METHODS: Case-control studies involved 203 incident HCC cases, 406 controls matched to the HCC cases for age (+/- 4 years) and sex, and 41 CLG cases (the HCC controls were used). They were carried out from August 1990 to August 1993.
RESULTS: Relative risk (RR) of HBsAg (87.4; 95% confidence interval [CI]: 22.2-344.3) and RR of anti-HCV positivity (30.3; 95% CI: 6.1-150.6) were significant for the risk of HCC after adjustment for potentially confounding factors. In contrast, RR of Clonorchis sinensis in stool (2.7; 95% CI: 1.1-6.3) and RR of heavy drinking (4.6; 95% CI: 1.4-15.2) were significant for the risk of CLG. Transfusion history, acupuncture history, and cigarette smoking were not associated with the risk of HCC or CLG.
CONCLUSIONS: Strong evidence indicated that both HBV and HCV infection were independent risk factors for HCC. In contrast, C. sinensis in stools and heavy drinking were associated with the risk of CLG in Korea.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8921477     DOI: 10.1093/ije/25.5.933

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  71 in total

Review 1.  Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma.

Authors:  William C Palmer; Tushar Patel
Journal:  J Hepatol       Date:  2012-03-13       Impact factor: 25.083

2.  Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoprotein.

Authors:  Yan-Ming Zhou; Jia-Mei Yang; Bin Li; Zheng-Feng Yin; Feng Xu; Bin Wang; Peng Liu; Zhi-Min Li
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

3.  Microscopic examination of gallbladder stones improves rate of detection of Clonorchis sinensis infection.

Authors:  Tie Qiao; Rui-hong Ma; Xiao-bing Luo; Pei-ming Zheng; Zhen-liang Luo; Liu-qing Yang
Journal:  J Clin Microbiol       Date:  2013-05-22       Impact factor: 5.948

Review 4.  Cholangiocarcinoma.

Authors:  Nataliya Razumilava; Gregory J Gores
Journal:  Lancet       Date:  2014-02-26       Impact factor: 79.321

Review 5.  Imaging diagnosis of clonorchiasis.

Authors:  Dongil Choi; Sung Tae Hong
Journal:  Korean J Parasitol       Date:  2007-06       Impact factor: 1.341

6.  Gene expression profiling in mouse liver infected with Clonorchis sinensis metacercariae.

Authors:  Dong Min Kim; Byung-Sam Ko; Jung-Won Ju; Shin-Hyeong Cho; Suk-Jin Yang; Young Il Yeom; Tong-Soo Kim; Yonggwan Won; Il-Chul Kim
Journal:  Parasitol Res       Date:  2009-11-10       Impact factor: 2.289

Review 7.  Clonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosis.

Authors:  Byung Ihn Choi; Joon Koo Han; Sung Tae Hong; Kyoung Ho Lee
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

8.  Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China.

Authors:  Yan-Ming Zhou; Zheng-Feng Yin; Jia-Mei Yang; Bin Li; Wen-Yu Shao; Feng Xu; Yu-Lan Wang; Dian-Qi Li
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

9.  Descriptive epidemiology of cholangiocarcinoma and clonorchiasis in Korea.

Authors:  Hai-Rim Shin; Jin-Kyoung Oh; Min Kyung Lim; Aesun Shin; Hyun-Joo Kong; Kyu-Won Jung; Young-Joo Won; Sohee Park; Sang-Jae Park; Sung-Tae Hong
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

10.  Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer.

Authors:  T Uenishi; S Kubo; K Hirohashi; H Tanaka; T Shuto; T Yamamoto; S Nishiguchi
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.